Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in differentin vitromodels
Author:
Affiliation:
1. Laboratory of Medical Biochemistry; Department of Pharmaceutical Sciences; University of Antwerp; Wilrijk Belgium
2. Laboratory for Vascular Translational Sciences; U1148; Paris Diderot University; Paris France
Funder
Fonds Wetenschappelijk Onderzoek
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14249/fullpdf
Reference45 articles.
1. Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?;Willemse;J Thromb Haemost,2009
2. Novel or expanding current targets in fibrinolysis;Wyseure;Drug Discov Today,2014
3. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets;Mosnier;Blood,2003
4. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B;Sakharov;J Biol Chem,1997
5. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin;Schneider;J Biol Chem,2004
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Differential Gene Expression in the Upper Respiratory Tract following Acute COVID-19 Infection in Ambulatory Patients That Develop Long COVID;Pathogens;2024-06-17
2. Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individuals;Journal of Thrombosis and Haemostasis;2023-05
3. A Feasibility Study on the Identification of Potential Biomarkers in Pulmonary Embolism Using Proteomic Analysis;Clinical and Applied Thrombosis/Hemostasis;2022-01
4. Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlations;PeerJ;2021-09-15
5. Evolutionary Inference Predicts Novel ACE2 Protein Interactions Relevant to COVID-19 Pathologies;2021-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3